Chronic lymphocytic leukemia (CLL) is a slow-growing cancer ... recurrent infections low blood cell counts fatigue or night sweats painful lymph nodes If you have intermediate or high risk CLL ...

Chronic lymphocytic leukemia (CLL) is a type of cancer ... a doctor may use one of two blood test types: complete blood count and blood cell exam or flow cytometry. During a complete blood count ...

Low hemoglobin has many causes, including leukemia. If the mini health assessment shows a person has a low red cell count or anemia, they cannot donate blood. Rarely, infection with HTLV-1 can ...

Relapsed or refractory acute leukemia with a KMT2A translocation currently ... data from the AUGMENT-101 clinical trial in which 21% of patients reached complete remission with partial hematological ...

The cat was feline leukemia virus (FeLV) negative and feline immuno-deficiency virus (FIV) negative. Complete blood count showed anemia (PCV 18.6%) and electrophoresis revealed a polyclonal ...

Several other diseases can be confused with MDS, including: aplastic anemia certain leukemias, including acute leukemia and large granular lymphocytic ... CBC can determine whether the numbers of ...

Medically reviewed by Doru Paul, MD A low platelet count (thrombocytopenia) means your blood lacks the small cells needed to form clots. Common causes of low platelets include an autoimmune disease ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

In the phase 2 portion of the phase 1/2 AUGMENT-101 trial, 12 of 64 patients with relapsed or refractory mutant NPM1 acute ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

It is caused by genetic and environmental factors. Symptoms include infections, blood clots or bleeding/bruising. Leukemia is primarily diagnosed by physical examination such as pale skin and the ...

like B-cell chronic leukemia and T-cell leukemia, and these deeper understandings open the door to innovative approaches that can make a difference for blood cancer patients in the future.